JP2003534767A5 - - Google Patents

Download PDF

Info

Publication number
JP2003534767A5
JP2003534767A5 JP2000584067A JP2000584067A JP2003534767A5 JP 2003534767 A5 JP2003534767 A5 JP 2003534767A5 JP 2000584067 A JP2000584067 A JP 2000584067A JP 2000584067 A JP2000584067 A JP 2000584067A JP 2003534767 A5 JP2003534767 A5 JP 2003534767A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000584067A
Other languages
Japanese (ja)
Other versions
JP2003534767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/023687 external-priority patent/WO2000031258A2/en
Publication of JP2003534767A publication Critical patent/JP2003534767A/ja
Publication of JP2003534767A5 publication Critical patent/JP2003534767A5/ja
Withdrawn legal-status Critical Current

Links

JP2000584067A 1998-11-20 1999-10-13 ヒトオーファンｇタンパク質共役型受容体 Withdrawn JP2003534767A (ja)

Applications Claiming Priority (47)

Application Number Priority Date Filing Date Title
US10921398P 1998-11-20 1998-11-20
US60/109,213 1998-11-20
US12041699P 1999-02-16 1999-02-16
US60/120,416 1999-02-16
US12185299P 1999-02-26 1999-02-26
US60/121,852 1999-02-26
US12394999P 1999-03-12 1999-03-12
US12394699P 1999-03-12 1999-03-12
US60/123,949 1999-03-12
US60/123,946 1999-03-12
US13712799P 1999-05-28 1999-05-28
US13656799P 1999-05-28 1999-05-28
US13643999P 1999-05-28 1999-05-28
US13643699P 1999-05-28 1999-05-28
US13643799P 1999-05-28 1999-05-28
US13713199P 1999-05-28 1999-05-28
US60/137,127 1999-05-28
US60/136,436 1999-05-28
US60/136,437 1999-05-28
US60/137,131 1999-05-28
US60/136,567 1999-05-28
US60/136,439 1999-05-28
US14144899P 1999-06-29 1999-06-29
US60/141,448 1999-06-29
US15665399P 1999-09-29 1999-09-29
US15655599P 1999-09-29 1999-09-29
US15663499P 1999-09-29 1999-09-29
US15663399P 1999-09-29 1999-09-29
US60/156,555 1999-09-29
US60/156,633 1999-09-29
US60/156,634 1999-09-29
US60/156,653 1999-09-29
US15729499P 1999-10-01 1999-10-01
US15728099P 1999-10-01 1999-10-01
US15728299P 1999-10-01 1999-10-01
US15729399P 1999-10-01 1999-10-01
US15728199P 1999-10-01 1999-10-01
US60/157,281 1999-10-01
US60/157,280 1999-10-01
US60/157,294 1999-10-01
US60/157,293 1999-10-01
US60/157,282 1999-10-01
US41676099A 1999-10-12 1999-10-12
US41704499A 1999-10-12 1999-10-12
US09/416,760 1999-10-12
US09/417,044 1999-10-12
PCT/US1999/023687 WO2000031258A2 (en) 1998-11-20 1999-10-13 Human orphan g protein-coupled receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004132989A Division JP2004267216A (ja) 1998-11-20 2004-04-28 ヒトオーファンｇタンパク質共役型受容体

Publications (2)

Publication Number Publication Date
JP2003534767A JP2003534767A (ja) 2003-11-25
JP2003534767A5 true JP2003534767A5 (enExample) 2005-11-17

Family

ID=27586698

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000584067A Withdrawn JP2003534767A (ja) 1998-11-20 1999-10-13 ヒトオーファンｇタンパク質共役型受容体
JP2004132989A Withdrawn JP2004267216A (ja) 1998-11-20 2004-04-28 ヒトオーファンｇタンパク質共役型受容体
JP2007129923A Pending JP2007209352A (ja) 1998-11-20 2007-05-15 ヒトオーファンｇタンパク質共役型受容体
JP2008033839A Pending JP2008133300A (ja) 1998-11-20 2008-02-14 ヒトオーファンｇタンパク質共役型受容体
JP2009159339A Withdrawn JP2009298791A (ja) 1998-11-20 2009-07-03 ヒトオーファンｇタンパク質共役型受容体

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2004132989A Withdrawn JP2004267216A (ja) 1998-11-20 2004-04-28 ヒトオーファンｇタンパク質共役型受容体
JP2007129923A Pending JP2007209352A (ja) 1998-11-20 2007-05-15 ヒトオーファンｇタンパク質共役型受容体
JP2008033839A Pending JP2008133300A (ja) 1998-11-20 2008-02-14 ヒトオーファンｇタンパク質共役型受容体
JP2009159339A Withdrawn JP2009298791A (ja) 1998-11-20 2009-07-03 ヒトオーファンｇタンパク質共役型受容体

Country Status (12)

Country Link
EP (8) EP1849866B1 (enExample)
JP (5) JP2003534767A (enExample)
KR (5) KR100926209B1 (enExample)
AT (3) ATE396400T1 (enExample)
AU (2) AU770056B2 (enExample)
CA (2) CA2645717A1 (enExample)
DK (3) DK1584683T3 (enExample)
ES (3) ES2243095T3 (enExample)
IL (2) IL142538A0 (enExample)
NZ (3) NZ527622A (enExample)
PT (3) PT1133559E (enExample)
WO (1) WO2000031258A2 (enExample)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69931360T2 (de) * 1998-03-12 2007-02-08 Astellas Pharma Inc. Neue, an ein g-protein gekoppelte rezeptorproteine
WO1999055733A1 (en) * 1998-04-24 1999-11-04 Smithkline Beecham Corporation Cloning of a novel 7tm receptor axor-2
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
EP1155031A4 (en) * 1998-11-03 2002-11-27 Smithkline Beecham Corp G PROTEIN TORQUE RECEPTOR, SAID AXOR-14
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
EP1157038A4 (en) * 1999-02-26 2005-01-19 Smithkline Beecham Corp CLONING OF A P2Y-LIKE 7TM RECEPTOR (AXOR17)
US6620615B1 (en) * 1999-04-23 2003-09-16 Curagen Corporation G-protein coupled receptor—encoding nucleic acids
EP1189944A4 (en) * 1999-06-21 2002-09-11 Smithkline Beecham Corp AXOR16, R CEPTEUR COUPL UNE PROT INE G
JP2003504054A (ja) * 1999-07-13 2003-02-04 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｇ−タンパク質共役型受容体およびそのｄｎａ配列
WO2001009313A1 (en) * 1999-07-30 2001-02-08 Merck Patent Gmbh G-protein coupled receptor and dna sequences thereof
CA2382889A1 (en) * 1999-08-27 2001-03-08 Takuya Watanabe Novel g protein-coupled receptor protein and dna thereof
US6998255B1 (en) 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
US6204017B1 (en) * 1999-10-07 2001-03-20 Schering Corporation Polynucleotide encoding a histamine receptor
GB9923893D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
GB9924956D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
EP1230361A2 (en) * 1999-10-27 2002-08-14 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors expressed in human brain
DE60036676T2 (de) * 1999-10-29 2008-02-07 Pfizer Inc. G-protein-gekoppelte rezeptor-ähnliche proteine
WO2001032864A2 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Gpcr-kd5 polypeptides and dna sequences thereof
US6461836B1 (en) 1999-11-05 2002-10-08 Smithkline Beecham Corporation Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
US7029857B1 (en) 1999-12-17 2006-04-18 H. Lundbeck A/S Processes for obtaining compounds employing SNORF72 receptors
WO2001046414A1 (fr) * 1999-12-20 2001-06-28 Banyu Pharmaceutical Co., Ltd. Nouvelle proteine receptrice couplee a la proteine de fixation de guanosine triphosphate, bg26
US6762029B2 (en) 1999-12-23 2004-07-13 Portola Pharmaceuticals, Inc. Methods of identifying agents that modulate P2Y12 receptor activity
WO2001048189A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a une proteine de liaison au guanosine triphosphate, genes de ces derniers, et production et utilisation de ces derniers
GB0001700D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Novel protein
CN1397019A (zh) * 2000-02-04 2003-02-12 武田药品工业株式会社 筛选方法
DE60127102T2 (de) * 2000-03-14 2007-08-23 Bayer Healthcare Aktiengesellschaft Regulation des menschliches lipoxin a4 rezeptor-ähnliches protein
EP1268777A2 (en) * 2000-03-17 2003-01-02 Bayer Aktiengesellschaft Regulation of human leukotriene b 4?-like g protein-coupled receptor
AU2001241156A1 (en) * 2000-03-21 2001-10-03 Yamanouchi Pharmaceutical Co..Ltd. Novel leukotriene b4 receptor
AU2001242800A1 (en) * 2000-03-28 2001-10-08 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
AU4467301A (en) * 2000-03-31 2001-10-08 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same
AU2001248755A1 (en) * 2000-04-12 2001-10-23 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
EP1178110A1 (en) * 2000-08-01 2002-02-06 Aventis Pharma Deutschland GmbH EDG8 receptor for sphingosine 1-phosphate , its preparation and use
ATE348162T1 (de) * 2000-05-18 2007-01-15 Bayer Healthcare Ag Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.
WO2002000719A2 (en) * 2000-06-23 2002-01-03 Tularik Inc. Human and mouse g-protein couipled receptors
WO2002000725A2 (en) * 2000-06-26 2002-01-03 Akzo Nobel N.V. G-protein coupled receptor org10
AU2001281933A1 (en) * 2000-06-30 2002-01-14 Ingenium Pharmaceuticals Ag Human g protein-coupled receptor igpcr17, and uses therof
AU2001271838A1 (en) 2000-07-06 2002-01-21 Bayer Corporation Human neuropeptide y-like g protein-coupled receptor
EP1311546A2 (en) * 2000-08-09 2003-05-21 Millenium Pharmaceuticals, Inc. Methods for using 14266, a human g protein-coupled receptor
US6790608B2 (en) 2000-09-20 2004-09-14 The Regents Of The University Of California Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist
WO2002036631A1 (en) * 2000-11-01 2002-05-10 Yamanouchi Pharmaceutical Co., Ltd. Method of screening antiplatelet
EP1337558B1 (en) * 2000-11-07 2010-09-01 Takeda Pharmaceutical Company Limited A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
WO2002042461A2 (en) * 2000-11-27 2002-05-30 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1770159A1 (en) 2000-12-01 2007-04-04 Astellas Pharma Inc. Process for manufacturing a pharmaceutical composition for treating diabetes
WO2002052047A2 (en) * 2000-12-22 2002-07-04 Mergen Ltd. Methods for identifying g-protein coupled receptors associated with diseases
AU2002246680A1 (en) 2000-12-22 2002-07-30 University Of South Florida Sphingosine 1-phosphate receptor gene, sppr
GB0100782D0 (en) * 2001-01-11 2001-02-21 Glaxo Group Ltd Assay
DE60228559D1 (de) * 2001-04-25 2008-10-09 Astellas Pharma Inc Guanosintriphosphat-bindungsprotein-gekoppelter rezeptor place 6002312 und sein gen sowie dessen produktion und verwendung
US7419658B2 (en) 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US7858755B2 (en) 2001-07-09 2010-12-28 Euroscreen S.A. Monoclonal antibodies that bind Chemerin polypeptide
US6946244B2 (en) * 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
JP4594623B2 (ja) 2002-04-12 2010-12-08 シェーリング コーポレイション Ｇタンパク質共役レセプターリガンドおよび方法
AU2003261874A1 (en) * 2002-09-02 2004-03-29 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
WO2004033687A1 (ja) * 2002-10-11 2004-04-22 Yamanouchi Pharmaceutical Co., Ltd. 腎不全治療薬をスクリーニングする方法
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
EP1581509B1 (en) 2002-12-20 2011-01-19 Merck Sharp & Dohme Corp. 1-(amino)indanes as edg receptor agonists
HRP20050696B1 (en) 2003-01-14 2008-10-31 Arena Pharmaceuticals Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
WO2005010152A2 (en) * 2003-06-27 2005-02-03 Tanox, Inc. Human mast cell-expressed membrane protein
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
GB0508990D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
DE602007010420D1 (de) 2006-04-11 2010-12-23 Arena Pharm Inc Verfahren zur verwendung des gpr119-rezeptors zur identifizierung von verbindungen zur erhöhung der knochenmasse bei einer person
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP2185544B1 (en) 2007-07-19 2014-11-26 Cymabay Therapeutics, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
BRPI0817211A2 (pt) 2007-09-20 2017-05-16 Irm Llc composto composições como moduladores da atividade de gpr119
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
WO2011127051A1 (en) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
BR112012032248A2 (pt) 2010-06-23 2016-09-13 Metabolex Inc composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
MX2013003184A (es) 2010-09-22 2013-06-07 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
WO2018236896A1 (en) 2017-06-19 2018-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of nafld and nash
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0868510A2 (en) * 1995-11-15 1998-10-07 Cor Therapeutics, Inc. P2u2 PURINERGIC RECEPTOR
JP2000505644A (ja) * 1996-01-11 2000-05-16 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｇタンパク質結合レセプター
WO1998031810A2 (en) * 1997-01-21 1998-07-23 Schering Corporation Mammalian chemokines; receptors; reagents; uses
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US5955303A (en) * 1997-03-06 1999-09-21 Incyte Pharmaceuticals, Inc. Human chemokine receptor-like protein
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6060272A (en) * 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
EP0899332A3 (en) * 1997-08-15 2000-07-05 Smithkline Beecham Corporation The G-protein coupled receptor HFIAO41
CA2239255A1 (en) * 1997-10-23 1999-04-23 Smithkline Beecham Corporation Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
WO1999024569A1 (fr) * 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Recepteur d'acide lysophosphatidique humain et utilisation dudit recepteur
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
WO1999042484A1 (en) * 1998-02-20 1999-08-26 Smithkline Beecham Corporation Fishboy, a g-protein coupled receptor
DE69931360T2 (de) * 1998-03-12 2007-02-08 Astellas Pharma Inc. Neue, an ein g-protein gekoppelte rezeptorproteine
WO1999052945A2 (en) * 1998-04-16 1999-10-21 Millenium Pharmaceuticals, Inc. NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
WO1999055733A1 (en) * 1998-04-24 1999-11-04 Smithkline Beecham Corporation Cloning of a novel 7tm receptor axor-2
SE9801455D0 (sv) * 1998-04-24 1998-04-24 Astra Pharma Inc New receptor
WO2000011166A1 (en) * 1998-08-19 2000-03-02 Millennium Pharmaceuticals, Inc. 14274 receptor, a g-protein coupled receptor related to the edg receptor family
JP2003532369A (ja) * 1998-08-20 2003-11-05 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｇタンパク質結合受容体である１４４００受容体
WO2000011015A1 (en) * 1998-08-24 2000-03-02 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
AU5801099A (en) * 1998-09-02 2000-03-21 Millennium Pharmaceuticals, Inc. 14926 receptor, a novel g-protein coupled receptor
KR20010080882A (ko) * 1998-10-13 2001-08-25 리처드 피. 버군 쥬니어 구성적으로 활성화된 비내생성 인간 ｇ 단백질 결합형수용체
JP2004500013A (ja) * 1998-10-16 2004-01-08 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 新規ｇタンパク質共役受容体
WO2000026369A1 (en) * 1998-11-04 2000-05-11 Chiron Corporation Isolated vshk-1 receptor polypeptides and methods of use thereof
WO2000028028A1 (en) * 1998-11-06 2000-05-18 Millennium Pharmaceuticals, Inc. G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6689866B1 (en) * 1999-03-09 2004-02-10 Curagen Corporation Polynucleotides and proteins encoded thereby
US6590938B1 (en) * 1999-09-30 2003-07-08 Conexant Systems, Inc. DCT domain conversion of a higher definition signal to lower definition signal
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
JP2002533830A5 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
BE2010C011I2 (enExample)
JP2002526128A5 (enExample)
JP2003534767A5 (enExample)
BE2008C047I2 (enExample)
BE2011C004I2 (enExample)
JP2002533203A5 (enExample)
JP2002531907A5 (enExample)
HUP1300369A2 (enExample)
JP2002503593A5 (enExample)
JP2002519935A5 (enExample)
DE60039363D1 (enExample)
JP2002510068A5 (enExample)